New Hampshire weighs titer-based rabies vaccine exemptions

Version 2

A New Hampshire proposal to loosen rabies booster requirements for some pets has surfaced a familiar fault line in veterinary medicine: pet parent concern about vaccine adverse events versus the public health framework that treats rabies vaccination as a legal and epidemiologic safeguard, not just an individual patient decision. House Bill 1488 would allow a veterinarian to support a rabies vaccination exemption for a dog, cat, or ferret based on antibody titer testing, creating a potential alternative to the state’s current, more restrictive exemption process. But the measure hasn’t advanced into law; as of April 1, 2026, it was marked for interim study following House action on March 11. (citizenscount.org)

Under current New Hampshire law, pets older than 3 months must receive an initial rabies vaccine and then boosters on the schedule set by the most current NASPHV Compendium. The existing exemption route is relatively narrow, requiring a written recommendation from a licensed veterinarian, an American College of Veterinary Internal Medicine diplomate, and the state veterinarian before the local rabies control authority can issue an exemption. HB 1488 would preserve that pathway, but also create a second option based on a single veterinarian’s recommendation tied to titer testing. (newhampshirebulletin.com)

The bill text, as indexed in legislative tracking, outlines a more structured testing protocol than some headlines suggest. It describes baseline rabies antibody titer testing before vaccination and a second titer 7 to 14 days after vaccination to establish the animal’s individual immune response, with the veterinarian then using that information to support an exemption recommendation. That’s notable because the proposal is not simply asking whether a pet has “some” antibodies at one point in time; it attempts to formalize an anamnestic-response framework. Even so, that approach runs into a longstanding scientific and regulatory barrier: U.S. rabies policy does not treat antibody titers as a validated substitute for current vaccination status in dogs, cats, and ferrets. (bills.nhliberty.org)

That’s where the veterinary and public health pushback is likely to remain strongest. The NASPHV Compendium states that rabies virus antibody titers indicate a response to vaccine or infection, but “do not directly correlate with protection,” and therefore should not be used in place of current vaccination for exposure management or booster decisions. AAHA’s canine vaccination guidance echoes that point, stating that serologic testing is not considered a substitute for rabies vaccination and emphasizing that legal exemptions are only available in some jurisdictions. AAHA also notes that rabies vaccines are highly effective, that vaccine failures are rarely reported, and that the domestic canine rabies virus variant was eliminated in the U.S. by 2008 through control programs and routine vaccination. (nasphv.org)

The industry reaction reflected in reporting has centered on that disconnect. According to the New Hampshire Bulletin’s account of the February 17 committee hearing, supporters argued the current exemption process is too difficult for pets with prior vaccine concerns, while state officials and veterinarians raised questions about the scientific validity and public health implications of using titers this way. The Bulletin also reported that State Veterinarian Mark Prescott addressed lawmakers during the hearing, underscoring that this is not just a small-animal medicine issue, but a state oversight and rabies control issue. (newhampshirebulletin.com)

Why it matters: For veterinary professionals, the proposal is less about whether antibodies can be measured, and more about what counts as legally meaningful protection. If a titer-based exemption were recognized in statute, clinics could see more requests for rabies deferrals from pet parents who view laboratory evidence of prior response as safer or more individualized than revaccination. That would raise practical questions around informed consent, medical record language, adverse-event counseling, local licensing, boarding requirements, interstate movement, and post-exposure case management. It could also place practitioners in a tighter liability position if a pet with a titer-based exemption bites a person or is exposed to a suspect rabid animal, because national guidance still treats current vaccination status, not antibody presence, as the operational standard. (nasphv.org)

There’s also a broader policy signal here. New Hampshire already has a medical exemption mechanism, and HB 1488 appears to test whether lawmakers are willing to move from case-by-case medical necessity toward a more permissive, test-based alternative. That would put the state at odds with the mainstream veterinary consensus on rabies immunization policy, even if supporters frame it as a limited option for selected patients. An important nuance for clinics is that a positive titer may reassure a pet parent, but it doesn’t automatically change how public health authorities, boarding facilities, or destination states interpret rabies status. That’s an inference based on current guidance and regulatory norms, rather than a direct statement from this bill alone. (nasphv.org)

What to watch: The next step is whether interim study leads lawmakers to amend the bill, shelve it, or reintroduce a narrower version focused on medically fragile animals; veterinary groups and state public health officials will likely have outsized influence on whatever comes back. (citizenscount.org)